CHYM plans Rule 144 sale of 117,000 common shares

CHYM filed a notice of proposed sale of common stock under Rule 144.

Rhea-AI Filing Summary

CHYM filed a notice of proposed sale of common stock under Rule 144. A brokerage account at Morgan Stanley Smith Barney LLC plans to sell 117,000 common shares, with an aggregate market value of $3,656,250.00, against 347,019,852 shares outstanding as of the filing, with sales expected around August 7, 2026. The shares relate to 67,157 Restricted Stock Units granted June 12, 2025 and 49,843 shares from previously exercised stock options dated October 22, 2019. The filing also reports prior 10b5-1 sales by Alexandra Britt of 200,000 common shares on August 6, 2026 for proceeds of $5,838,010.00.

Key Figures

Proposed shares to be sold: 117,000 shares Aggregate market value of proposed sale: $3,656,250.00 Shares outstanding: 347,019,852 shares +4 more

7 metrics

Proposed shares to be sold 117,000 shares Common stock proposed for sale under Rule 144

Aggregate market value of proposed sale $3,656,250.00 Value of 117,000 common shares to be sold

Shares outstanding 347,019,852 shares Common shares outstanding referenced in the filing

Restricted Stock Units linked 67,157 units RSUs dated June 12, 2025 related to shares to be sold

Previously exercised stock options 49,843 shares Shares from options dated October 22, 2019

Recent 10b5-1 shares sold 200,000 shares 10b5-1 sales on August 6, 2026 for Alexandra Britt

Proceeds from recent 10b5-1 sales $5,838,010.00 Total proceeds from 200,000-share sale on August 6, 2026

Key Terms

Rule 144, Restricted Stock Units, 10b5-1 sales, Previously Exercised Stock Options

4 terms

Rule 144 regulatory

"filed a notice of proposed sale of common stock under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"67,157 Restricted Stock Units granted June 12, 2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 sales regulatory

"The filing also reports prior 10b5-1 sales by Alexandra Britt"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Previously Exercised Stock Options financial

"49,843 shares from previously exercised stock options dated October 22, 2019"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is CHYM reporting in this Form 144 filing?

CHYM reports a planned sale of 117,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $3,656,250.00, in reliance on Rule 144 for resales of restricted or control securities.

How large is the proposed CHYM share sale compared to shares outstanding?

The proposed sale covers 117,000 common shares, while total common shares outstanding are listed as 347,019,852. This shows the filing relates to a relatively small portion of the overall outstanding shares.

What CHYM equity awards are tied to the shares to be sold?

The filing links the planned sale to 67,157 Restricted Stock Units granted on June 12, 2025 and 49,843 shares from previously exercised stock options originally dated October 22, 2019, all issued by the company.

What recent 10b5-1 sales related to CHYM stock are disclosed?

The filing notes 10b5-1 sales for Alexandra Britt of 200,000 CHYM common shares on August 6, 2026, with total proceeds of $5,838,010.00, indicating trades executed under a pre-arranged trading plan.

Who is the broker handling the proposed CHYM Rule 144 sale?

The proposed Rule 144 sale of 117,000 CHYM common shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which exchange is CHYM common stock listed in this filing?

The Form 144 identifies CHYM’s common stock as trading on the NASDAQ market, providing context for where the proposed 117,000-share sale would occur.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:37 PM Accepted by SEC EDGAR 08/07/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002061801
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Chime Financial, Inc.
SEC File Number	001-42693
Address of Issuer	101 California Street, Suite 500 San Francisco CALIFORNIA 94111
Phone	8442446363
Name of Person for Whose Account the Securities are To Be Sold	BRITT LIVING TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	117000	3656250.00	347019852	08/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2025	Restricted Stock Units	Issuer			67157	06/12/2025	N/A
Common	10/22/2019	Previously Exercised Stock Options	Issuer			49843	10/22/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ALEXANDRA BRITT 101 California Street, Suite 500 San Francisco CA 94111	Common	08/06/2026	200000	5838010.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 6/12/2025 through 5/15/2026.
Date of Notice	08/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher R Britt
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)